The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
Zsuzsanna Suba National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Budapest, Hungary Abstract: Although antiestrogens have been available for breast cancer therapy since the early 1970s, neither their inconsistent anticancer capacity nor the developing antiestrogen resista...
Saved in:
Main Author: | Suba Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens
by: Zsuzsanna Suba
Published: (2023) -
Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
by: Heidi M. Ekholm, et al.
Published: (2021) -
An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer
by: Huang Tim, et al.
Published: (2010) -
Antiestrógenos: mecanismo de acción y aplicaciones clínicas Antiestrogens: mechanism of action and clinical applications
by: Arturo Barrón-González, et al.
Published: (2001) -
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency
by: Stepan K. Krymov, et al.
Published: (2023)